Phathom Pharmaceuticals, Inc.(PHAT)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
PHAT has no upcoming report date in the calendar yet. It last reported on Oct 29, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±7.0%).
Did the stock rise after good news?
The next-day move after each of its last 6 EPS beats and 1 misses.
In plain words: it beat expectations 6 times, but the stock still fell 3 of those 6 times.
- Oct '26Beat▼ -1.0%
- Feb '26Beat▲ +10.1%
- Oct '25Beat▼ -1.6%
- Aug '25Beat▲ +8.3%
- Aug '24Missed▲ +8.7%
- Mar '24Beat▼ -6.6%
- Nov '23Beat▲ +0.5%
Clear beats and misses with a known reaction only. What counts as a beat
Why did PHAT fall after beating earnings?
4 of PHAT's last 7 reactions went against the EPS result. What stands out in each:
PHAT beat EPS estimates in 6 quarters, and the stock still closed lower the next day 3 times. In 2 of the 3 where we have price data, the stock had already run up before the report.
- Oct 29, 2026EPS beat +33.3%stock -1.0% next day
- Revenue came in 2.1% below estimates even though EPS beat.
- It opened 11.5% higher, but sellers took over and it closed -1.0%.
- Oct 30, 2025EPS beat +63.4%stock -1.6% next day
- It had risen 10.1% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 3.5% higher, but sellers took over and it closed -1.6%.
- Mar 7, 2024EPS beat +20.0%stock -6.6% next day
- It had risen 37.4% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 7.8% higher, but sellers took over and it closed -6.6%.
Rose despite an EPS miss (1 of 1)
- Aug 8, 2024EPS missed -0.8%stock +8.7% next day
- It had already fallen 8.5% in the final week before the report, so weak results may have been expected.
- The EPS miss was small (-0.8%).
- It opened 6.4% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was PHAT's earnings move already priced in?
PHAT's move in the month before each of its last 9 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 9 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does PHAT hold its opening gap after earnings?
PHAT's opening move after each report and where it closed that day.
In 9 reports PHAT opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 9 times (44%), and fully reversed 3 times. Gaps up faded 4 of 7; gaps down recovered 0 of 2.
- Oct 29, 2026ReversedOpened +11.5%, closed -1.0%
- Apr 30, 2026HeldOpened -2.7%, closed -4.9%
- Feb 26, 2026HeldOpened +5.5%, closed +10.1%
- Oct 30, 2025ReversedOpened +3.5%, closed -1.6%
- Aug 7, 2025HeldOpened +6.1%, closed +8.3%
- May 1, 2025HeldOpened -6.8%, closed -21.7%
- Aug 8, 2024HeldOpened +6.4%, closed +8.7%
- Mar 7, 2024ReversedOpened +7.8%, closed -6.6%
What the history says
- PHAT has beaten EPS estimates in 4 straight quarters (quarters where our data sources disagree are skipped).
- It fell after 3 of its 6 EPS beats (50%): beating estimates has not been enough on its own.
PHAT earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | Revenue surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Before open | $0.03 | $0.04 | +33.3% | -2.1% | -0.96% | — |
| Apr 30, 2026 | Before open | -$0.19 | -$0.18 | sources differ | — | -4.92% | +9.25% |
| Feb 26, 2026 | Before open | -$0.19 | -$0.08 | +57.9% | — | +10.06% | -6.98% |
| Oct 30, 2025 | Before open | -$0.41 | -$0.15 | +63.4% | — | -1.63% | +1.48% |
| Aug 7, 2025 | Before open | -$0.92 | -$0.79 | +14.1% | — | +8.29% | +18.43% |
| May 1, 2025 | Before open | -$1.07 | -$1.07 | 0.0% | — | -21.68% | -39.86% |
| Mar 6, 2025 | Before open | -$1.08 | -$1.05 | +2.8% | — | — | — |
| Nov 7, 2024 | Before open | -$1.46 | -$1.05 | +28.1% | — | — | — |
| Aug 8, 2024 | Before open | -$1.24 | -$1.25 | -0.8% | — | +8.70% | +11.29% |
| May 9, 2024 | Before open | -$1.22 | -$1.11 | +9.0% | — | — | — |
| Mar 7, 2024 | Before open | -$1.00 | -$0.80 | +20.0% | — | -6.58% | -15.11% |
| Nov 9, 2023 | Before open | -$0.96 | -$0.76 | +20.8% | — | +0.51% | -8.57% |
PHAT Earnings FAQ
Answers computed from Phathom Pharmaceuticals, Inc.'s reported history
PHAT has no upcoming report date in the calendar yet. It last reported on Oct 29, 2026; companies usually report every three months.
Over the last 11 quarters with a usable EPS surprise, PHAT beat the consensus estimate 9 times (82%), missed 1 and landed in line 1. It has beaten estimates in each of the last 4 counted quarters. 1 quarter where our data sources disagree on beat versus miss are shown but not counted.
Across its last 9 quarters with a measured reaction, PHAT moved an average of ±7.0% in the first session after reporting. It closed higher 44% of the time; the largest gain was 10.1% and the largest drop -21.7%.
PHAT fell in the first session after 3 of its last 6 EPS beats (50%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 2 of the 3 of those falls where price data is available, the stock had already risen before the report.
Across its last 9 quarters with price data, PHAT moved an average of -1.9% in the 20 trading sessions before reporting and was higher in 44% of them. After a run-up of 3% or more (4 quarters), it fell the next day 75% of the time, averaging -1.1%. After a drop of 3% or more (5 quarters), it rose the next day 60% of the time, averaging -0.8%. This describes past reports; it is not a forecast.
In 9 reports PHAT opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 9 times (44%), and fully reversed 3 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · PHAT: 12 reported quarters, latest Oct 29, 2026. Information only, not investment advice.
Looking for more on PHAT?
Price charts, forecast, fundamentals and risk pages for PHAT are not on Tickzen yet. You can run a full stock analysis now.
Run the PHAT Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun